These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 24897301
1. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro. Hu W, Liu Y, Zhou W, Si L, Ren L. PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301 [Abstract] [Full Text] [Related]
2. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering. Singh R, Kapur N, Mir H, Singh N, Lillard JW, Singh S. Oncotarget; 2016 Feb 09; 7(6):7343-53. PubMed ID: 26799186 [Abstract] [Full Text] [Related]
3. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer. Ha HK, Lee W, Park HJ, Lee SD, Lee JZ, Chung MK. Mol Med Rep; 2011 Feb 09; 4(3):419-24. PubMed ID: 21468586 [Abstract] [Full Text] [Related]
4. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma. Guo L, Cui ZM, Zhang J, Huang Y. Chin J Cancer; 2011 May 09; 30(5):336-43. PubMed ID: 21527066 [Abstract] [Full Text] [Related]
5. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. Hu W, Zhen X, Xiong B, Wang B, Zhang W, Zhou W. Cancer Sci; 2008 Jul 09; 99(7):1362-9. PubMed ID: 18452560 [Abstract] [Full Text] [Related]
6. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation. Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E. Cancer Res; 2008 Jun 15; 68(12):4701-8. PubMed ID: 18559516 [Abstract] [Full Text] [Related]
7. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer. Huang Y, Zhang J, Cui ZM, Zhao J, Zheng Y. Chin J Cancer; 2013 May 15; 32(5):289-96. PubMed ID: 22958742 [Abstract] [Full Text] [Related]
8. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers. Darash-Yahana M, Gillespie JW, Hewitt SM, Chen YY, Maeda S, Stein I, Singh SP, Bedolla RB, Peled A, Troyer DA, Pikarsky E, Karin M, Farber JM. PLoS One; 2009 Aug 19; 4(8):e6695. PubMed ID: 19690611 [Abstract] [Full Text] [Related]
9. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro. Lu Y, Wang J, Xu Y, Koch AE, Cai Z, Chen X, Galson DL, Taichman RS, Zhang J. Mol Cancer Res; 2008 Apr 19; 6(4):546-54. PubMed ID: 18344492 [Abstract] [Full Text] [Related]
10. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms. Xiao G, Wang X, Wang J, Zu L, Cheng G, Hao M, Sun X, Xue Y, Lu J, Wang J. Oncotarget; 2015 Jun 10; 6(16):14165-78. PubMed ID: 25909173 [Abstract] [Full Text] [Related]
11. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer]. Zhou WH, Hu WD, Wu ZQ, Zheng XM, Wang BC. Zhonghua Yi Xue Za Zhi; 2010 Apr 13; 90(14):947-51. PubMed ID: 20646641 [Abstract] [Full Text] [Related]
12. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor. Yoon MS, Pham CT, Phan MT, Shin DJ, Jang YY, Park MH, Kim SK, Kim S, Cho D. Cytotherapy; 2016 Dec 13; 18(12):1532-1542. PubMed ID: 27720639 [Abstract] [Full Text] [Related]
13. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Wente MN, Gaida MM, Mayer C, Michalski CW, Haag N, Giese T, Felix K, Bergmann F, Giese NA, Friess H. Int J Oncol; 2008 Aug 13; 33(2):297-308. PubMed ID: 18636150 [Abstract] [Full Text] [Related]
14. Escin suppresses migration and invasion involving the alteration of CXCL16/CXCR6 axis in human gastric adenocarcinoma AGS cells. Lee HS, Hong JE, Kim EJ, Kim SH. Nutr Cancer; 2014 Aug 13; 66(6):938-45. PubMed ID: 24911042 [Abstract] [Full Text] [Related]
15. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome. Lv Y, Hou X, Ti Y, Bu P. Clin Nutr; 2013 Oct 13; 32(5):849-54. PubMed ID: 23398954 [Abstract] [Full Text] [Related]
16. The CXCL16 A181V mutation selectively inhibits monocyte adhesion to CXCR6 but is not associated with human coronary heart disease. Petit SJ, Wise EL, Chambers JC, Sehmi J, Chayen NE, Kooner JS, Pease JE. Arterioscler Thromb Vasc Biol; 2011 Apr 13; 31(4):914-20. PubMed ID: 21233446 [Abstract] [Full Text] [Related]
17. [Expressions of CXCL16/CXCR6 and CXCL12/CXCR4 in first-trimester human trophoblast cells]. Huang Y, Li DJ, Wang MY, Cheng HD. Zhonghua Fu Chan Ke Za Zhi; 2006 Jun 13; 41(6):399-402. PubMed ID: 16831364 [Abstract] [Full Text] [Related]
18. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation. Diegelmann J, Seiderer J, Niess JH, Haller D, Göke B, Reinecker HC, Brand S. Inflamm Bowel Dis; 2010 Nov 13; 16(11):1871-81. PubMed ID: 20848509 [Abstract] [Full Text] [Related]
19. The chemokine, CXCL16, and its receptor, CXCR6, are constitutively expressed in human annulus fibrosus and expression of CXCL16 is up-regulated by exposure to IL-1ß in vitro. Gruber HE, Marrero E, Ingram JA, Hoelscher GL, Hanley EN. Biotech Histochem; 2017 Nov 13; 92(1):7-14. PubMed ID: 27869573 [Abstract] [Full Text] [Related]
20. Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues. Manabe S, Iwase A, Goto M, Kobayashi H, Takikawa S, Nagatomo Y, Nakahara T, Bayasula, Nakamura T, Hirokawa W, Kikkawa F. Arch Gynecol Obstet; 2011 Dec 13; 284(6):1567-72. PubMed ID: 21773780 [Abstract] [Full Text] [Related] Page: [Next] [New Search]